Drugs / ME1111
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01841996 | Mar → Aug 2013 | tinea unguium | Meiji Seika Pharma Co., Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02022215 | Dec 2013 → Oct 2015 | tinea unguium | Meiji Seika Pharma Co., Ltd. | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2013-04-18 | Meiji Seika Pharma Co., Ltd. | Meiji Initiates Phase 1 Clinical Trial of ME1111 in U.S. for Topical Treatment of Onychomycosis meiji.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ME1111 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01841996 ↗ |
| Route | Topical | “ME1111 Topical Agent Applied to All Toenails” NCT01841996 ↗ |